Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies

Monoclonal Gammopathy of Undetermined Significance trial results

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +25 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
View all 207 locations
Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations
  • Beckman Research Institute, City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Los Angeles County-University of Southern California Medical Center Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States